Q3 2017 Holdings
Filed 2017-11-14 | 63 holdings | $14.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.6M | 47,459 | 39.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.2M | 33,347 | 15.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.1M | 6,687 | 14.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.9M | 19,926 | 13.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $741.0K | 133,500 | 5.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $589.0K | 15,639 | 4.2% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $535.0K | 4,955 | 3.8% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $413.0K | 21,009 | 2.9% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $8.0K | 130,500 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.7K | 90,000 | 0.0% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $5.6K | 65,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.4K | 83,700 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $4.9K | 35,000 | 0.0% |
| Ishares TR(IBB) | NASDAQ BIOTECH | 464287556 | $4.2K | 12,500 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.1K | 120,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $4.0K | 112,300 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $2.9K | 45,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.8K | 18,274 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.5K | 104,328 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.5K | 48,244 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.4K | 60,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $2.4K | 16,177 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.4K | 20,148 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.3K | 3,594 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $2.2K | 41,263 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.2K | 44,183 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $2.2K | 11,235 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $2.1K | 11,406 | 0.0% |
| Ignyta Inc | COM | 451731103 | $2.1K | 170,500 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.0K | 4,561 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $2.0K | 64,421 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $1.6K | 11,447 | 0.0% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $1.4K | 16,002 | 0.0% |
| Lilly ELI & Co(LLY)Call | COM | 532457108 | $1.3K | 15,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.3K | 13,800 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.2K | 15,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.1K | 100,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.0K | 40,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $939 | 25,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $810 | 10,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $660 | 14,720 | 0.0% |
| Tesaro Inc | COM | 881569107 | $646 | 5,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $635 | 30,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $634 | 11,899 | 0.0% |
| Bioverativ Inc | COM | 09075E100 | $631 | 11,056 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $591 | 9,644 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $543 | 24,805 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $524 | 6,462 | 0.0% |
| Medicines Co | COM | 584688105 | $519 | 14,000 | 0.0% |
| BIO Techne Corp(TECH) | COM | 09073M104 | $516 | 4,268 | 0.0% |